Sex differences in soluble prorenin receptor in patients with type 2 diabetes
Bruna Visniauskas(Tulane University), Minolfa C. Prieto(Tulane University), Gabrielle Dawkins(Tulane University), Danielle Yuri Arita(Tulane University), John J. Lefante(Tulane University), Michael J. Accavitti(Tulane University), Vivian Fonseca(Tulane University), Christina Luffman(Tulane University), Edgar A. Jaimes(Memorial Sloan Kettering Cancer Center), Franck Mauvais‐Jarvis(Tulane University), Andrew C. Curnow(Tulane University), Mohammed A. Feroz(Tulane University), C Rosales(Tulane University), Jennifer Hong(University of Groningen), Tina K. Thethi(Tulane University)
Cited by 15
Related Papers
Sex and gender: modifiers of health, disease, and medicine
|The Lancet|2020|2k
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
|Annals of Internal Medicine|2004|1.4k
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
|Endocrine Practice|2016|875